Salarius Pharmaceuticals Inc (NASDAQ:SLRX) price closed lower on Monday, March 25, dropping -17.74% below its previous close.
A look at the daily price movement shows that the last close reads $0.62. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.68 and 52-week low of $0.50. The stock subtracted -11.60% on its value in the past month.
Salarius Pharmaceuticals Inc, which has a market valuation of $2.01 million, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024. Analysts tracking SLRX have forecast the quarterly EPS to shrink by -1.01 per share this quarter, while the same analysts predict the annual EPS to hit -$5.32 for the year 2024 and up to -$4.63 for 2024. In this case, analysts estimate an annual EPS growth of 64.20% for the year and 13.00% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give SLRX a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that SLRX’s price is at present -20.48% off the SMA20 and -14.57% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 36.86, with weekly volatility standing at 18.79%. The indicator jumps to 12.46% when calculated based on the past 30 days. Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s beta value is holding at 1.02, while the average true range (ATR) indicator is currently reading 0.08.
An analysis of the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) stock in terms of its daily trading volume indicates that the 3-month average is 50.25K. However, this figure increases on the past 10-day timeline to an average of 0.12 million.
Current records show that the company has 3.94M in outstanding shares. The insiders’ percentage holdings are 7.38% of outstanding shares while the percentage share held by institutions stands at 6.67%. The stats also highlight that short interest as of Feb 29, 2024, stood at 18010.0 shares, which puts the short ratio at the time at 0.76. From this we can glean that short interest is 0.46% of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 8260.0. But the -21.54% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
